All 1 tracked stories fall under one category: regulation. Kratom is most often covered alongside Senate Committee, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kratom
All 1 tracked stories fall under one category: regulation. Kratom is most often covered alongside Senate Committee, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window. At 6, the average consequence score sits below the same-window beat average of 6.7. Kratom appears in 1 tracked Legal story from March 21, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 61 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kratom. Shared-story counts are live from our verified record — not editorial picks.
A Senate committee has introduced legislation to regulate the sale and manufacturing of kratom, pivoting away from previous efforts to ban the substance. The bill establishes consumer safety standards, including age restrictions and mandatory purity testing, aligning with the national 'Kratom Consumer Protection Act' movement.